Suzhou MedicalSystem Technology Valuation
Is 603990 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 603990 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 603990's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 603990's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 603990?
Other financial metrics that can be useful for relative valuation.
| What is 603990's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CN¥3.11b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 6.4x |
| Enterprise Value/EBITDA | -32.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 603990's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 7.7x | ||
688246 Goodwill E-Health Info | 4.6x | 22.9% | CN¥3.3b |
300550 Heren Health | 6.6x | n/a | CN¥2.8b |
301337 Yarward Electronics (Shandong) | 9.2x | n/a | CN¥3.3b |
300288 Longmaster Information & Technology | 10.4x | n/a | CN¥4.5b |
603990 Suzhou MedicalSystem Technology | 4.7x | 91.1% | CN¥3.1b |
Price-To-Sales vs Peers: 603990 is good value based on its Price-To-Sales Ratio (4.7x) compared to the peer average (7.7x).
Price to Earnings Ratio vs Industry
How does 603990's PE Ratio compare vs other companies in the Asian Healthcare Services Industry?
Price-To-Sales vs Industry: 603990 is good value based on its Price-To-Sales Ratio (4.7x) compared to the Asian Healthcare Services industry average (4.9x).
Price to Sales Ratio vs Fair Ratio
What is 603990's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 4.7x |
| Fair PS Ratio | 58.1x |
Price-To-Sales vs Fair Ratio: 603990 is good value based on its Price-To-Sales Ratio (4.7x) compared to the estimated Fair Price-To-Sales Ratio (58.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.